Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified SDD for Prevention of ICU Infections
NCT01798537Phase 3Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Jun 2013
- Primary completion
- Jul 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of neomycin, colistin, nystatin, vancomycin in Hospital-Acquired Infection (HAI), ventilator-associated pneumonia (VAP), Bacteremia, sponsored by Rambam Health Care Campus. Status: unknown.
02
Drugs
neomycincolistinnystatinvancomycin
03
Conditions
Hospital-Acquired Infection (HAI)ventilator-associated pneumonia (VAP)Bacteremia
Beyond the preview
Go deeper on NCT01798537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798537.